Indications
Ixchiq is indicated for active immunisation for the prevention of disease caused by chikungunya virus (CHIKV) in individuals between 12 years older. The use of this vaccine should be in accordance with official recommendations.
Composition
- Active substance
- Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
- International name (INN)
- Chikungunya vaccine (live)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Ixchiq
- Active substance
- Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated
- ATC code
- J07BP01
- Therapeutic area
- Chikungunya virus